Adimab private stock trade

Adimab

Legal NameAdimab, LLC
HeadquartersLebanon, NH
SectorHealthTech

Adimab is a biotechnology company that specializes in antibody discovery and optimization. It focuses on developing innovative solutions for the biopharmaceutical industry, particularly in the field of therapeutic antibody research. Adimab's expertise lies in using its proprietary antibody discovery platform to create and optimize antibodies with potential applications in treating various diseases. The company plays a crucial role in advancing the development of novel biopharmaceuticals by offering a robust technology platform and extensive industry experience to its clients.

Learn more about Adimab IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Adimab, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Adimab, log in to ZXData or contact us to request access.

Similar Companies

View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.